Products

Orthox Limited, the tissue repair company using silk technology, announced the award of a prestigious Wellcome Trust Translational Award worth over £1.6 million.

The CYPHER SELECT®Plus Sirolimus-eluting Coronary Stent has received CE marking within the European Union for treatment of patients with diabetes, a complex and often difficult-to-treat patient population.

Edwards Lifesciences Corporation announced today that it received CE Mark approval for European commercial sales of the new RetroFlex 3 transfemoral delivery system for the Edwards SAPIEN transcatheter heart valve.

BioSyntech, Inc., a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced its financial and operational results for the third quarter of fiscal 2009, ended December 31, 2008.

Corin Group PLC, a leading manufacturer and supplier of orthopaedic devices, has appointed Michael Roller Finance Director with effect from 2 March 2009, following the resignation of Simon Hartley on 12 February 2009.

Deal adds new product line to the Sorin Group’s core cardiovascular business franchise.

New lead and cardiac resynchronization system design is expected to offer implanting physicians a simpler and quicker procedure and reduces the volume of the leads and device in the chest pocket for heart failure patients

Aegis Can Now Be Marketed for Use in European Union.
Neovasc Also Announces Senior Management Changes and Issues Options.

Small Bone Innovations, Inc. (SBi) announced today that it has completed the acquisition of Link America, Inc., d/b/a Link Orthopaedics, The Scandinavian Total Ankle Replacement system, known as the ‘S.T.A.R.® Ankle’, and certain assets related to the S.T.A.R. Ankle.

Cardiac Dimensions®, Inc. today announced that it achieved the implant target for the TITAN™ safety study during the fourth quarter of 2008.

Supplement Features 15 Peer Reviewed Papers Describing CyberKnife Radiosurgery for Brain and Spine Applications

B. Braun gets favourable support from Penang State Government for Future Expansion Plans.

Agreement stops all litigation in interventional cardiology and endovascular repair.

Kinetic Concepts, Inc. today reported fourth quarter and full year 2008 total revenue of $492.5 million and $1.878 billion, respectively, an increase of 14% and 17% from the same respective periods of 2007.

St. Jude Medical, Inc. announced European CE Mark approval of its Libra® and LibraXP™ deep brain stimulation systems for treating the symptoms of Parkinson’s disease, a neurological disorder that progressively diminishes a person’s control over his or her movements and speech.

Biomedical engineers at The University of Texas Health Science Center at Houston are leading a multi-institution initiative to produce a bio-compatible compound designed to mend serious leg fractures.